AMI Cardiogenic Shock
Early Stabilization Can Improve Outcomes in Cardiogenic Shock
Impella® heart pumps have the ability to stabilize patient hemodynamics, unload the left ventricle, perfuse end organs, and allow for recovery of the native heart in patients with ongoing cardiogenic shock. Identifying patients early, treating them with a proven protocol, and following them with hemodynamic monitoring and aggressive down titration of inotropes and vasopressors can reverse the downward spiral of cardiogenic shock and help patients achieve myocardial recovery.
Resources for Health Care Professionals
DanGer Shock Randomized Controlled Trial (RCT) Confirms Routine Use of Impella CP® Heart Pump Improves Survival in Heart Attack with Shock
This investigator-initiated study is the first RCT of Impella in cardiogenic shock (CS), assessed the efficacy of Impella CP® with or without SmartAssist® heart pumps in treating patients with AMIC shock with STEMI, undergoing emergency PCI.
From Patient Selection to Escalation Strategies – Mechanical Circulatory Support in Cardiogenic Shock
Experts throughout Europe have contributed to these publications in the European Heart Journal Supplements with articles discussing best practices for successfully managing mechanical circulatory support (MCS) in patients with cardiogenic shock.
The articles cover topics in patient and device selection, best practices for timing, monitoring, escalation and weaning. Gain additional background information from exclusive author interviews and insights.
Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients - Clinical Best Practices
NPS-2633